Business Context and Reporting Period
Company: MEDICINOVA INC
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2013
Event: Entry into a Material Definitive Agreement (Sublease for new headquarters).
Key Financial Metrics
This filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on a corporate real estate transaction.
Material Changes
The Company entered into a sublease agreement with Denali Advisors LLC (with consent from master landlord Irvine Company) to relocate its headquarters.
- Location: 4275 Executive Square, Suite 650, La Jolla, California.
- Space: 5,219 square feet.
- Term: March 1, 2013, to November 30, 2017.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management commentary on future performance, or discussion of risks and contingencies beyond the execution of the sublease. The full terms of the agreement are referenced in Exhibit 10.1.
Investor Verification Checklist
- Review Exhibit 10.1 (Sublease Agreement) for specific rent obligations, escalation clauses, and termination rights.
- Verify the total cost of the relocation and any associated capital expenditures not detailed in this summary.
- Confirm the impact of the new lease term on the Company's future operating cash flow requirements.